The announcement comes a few weeks after the Food and Drug Administration approved a treatment from rival Biogen despite warnings from the agency's independent advisers that it hasn't been shown to help slow the brain-destroying disease.

Alzheimer's disease affects more than 5 million Americans, but the disease is still a mystery to scientists and doctors.

In Indiana, the number of patients with Alzheimer's is expected to grow by nearly 20 percent in the next five years, there are a number of new programs and opportunities for people to use music to support memory.

The Indiana University School of Medicine will partner with Purdue University to develop research tools and technologies to identify new treatment options.

More than five million Americans are living with Alzheimers, according to government estimates. Greg OBrien is one of them. Hes a journalist and co-host of The Forgetting, a podcast about living with the disease.

The first large-scale study of early onset Alzheimers disease is led out of Indiana. A new grant will enable the study to add on genetic research.

The class of drugs called anticholinergics are used to treat conditions ranging from depression to allergies. But they have been linked to an increased chance of developing Alzheimers or dementia.

The Longitudinal Early Onset Alzheimer's Disease or LEADS, study could help improve diagnosis and care as well as provide insight on potential therapies.

Since there's no cure for Alzheimer's disease, researchers are focused on ways to identify early signs and create treatments before dementia sets in.

An estimated 338,000 Hoosier family caregivers provide billions in unpaid care a year for people with Alzheimer's disease alone.